The average historical PE ratio of Medifast for the last ten years is 22.3. The current price-to-earnings ratio of 71.89 is in line with the historical average. Analyzing the last ten years, MED's PE ratio reached its highest point in the Dec 2024 quarter at 92.74, when the price was $17.62 and the EPS was $0.19. The lowest point was recorded in the Mar 2024 quarter, when it reached 6.17 with a price of $38.32 and an EPS of $6.21.
Maximum annual increase: 1,160.05% in 2024
Maximum annual decrease: -50.34% in 2011
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 92.74 | 1,160.05% | $17.62 | $0.19 |
2023 | 7.36 | -18.22% | $67.22 | $9.13 |
2022 | 9 | -39.8% | $115.35 | $12.82 |
2021 | 14.95 | -33.44% | $209.43 | $14.01 |
2020 | 22.46 | 35.71% | $196.34 | $8.74 |
2019 | 16.55 | -38.18% | $109.58 | $6.62 |
2018 | 26.77 | -11.03% | $125.02 | $4.67 |
Currently, MED's PE ratio is above its 3, 5 and 10-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
MED Medifast Inc | 69.21 | $143.83M |
WTW Willis Towers Watson Plc | N/A | $33.55B |
ABEO Abeona Therapeutics Inc | N/A | $227.62M |
As of Apr 2, 2025, MED stock has a price to earnings ratio of 71.89.
Over the last 3 years, the average PE ratio for MED stock is 17.84.
Over the last 5 years, the average PE ratio for MED stock is 18.09.
Over the last ten years, the quarterly PE ratio reached its highest level at 92.74 in the Dec 2024 quarter.
The current PE ratio of MED is 222% higher than the 10-year historical average.
MED's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Apr 2, 2025), Medifast's share price is $13.66. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.19. Therefore, Medifast's price to earnings ratio for today is 71.89. PE RATIO(71.89) = STOCK PRICE($13.66) / TTM EPS($0.19)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.